Our Social Media Pages, follow us and engage with the Pill-grim community!
And now for this week’s prescription:
On this week’s dose, we mix things up a bit with a status update for Sam and Brandon. The 138 week streak of weekly doses may soon come to an end. With each of us moving to new cities, there just isn’t as much time in the week as there used to be when the pod was based out of Austin. Don’t worry! We aren’t going anywhere. You just might not see a dose every single Thursday morning.
The second half of this week’s dose is a conversational breakdown of Interplay Learning (the company Sam works for) and their recent fundraising round led by Goldman Sachs’ Inclusive Growth Fund. With that announcement, Interplay also welcomes ITI (Industrial Training International) to the family. Tune in to hear more from Sam on the news and what’s ahead!
Sources:
Music Credit: Chapter One by Cole Bauer and Dean Keeton
Disclosure:
The views, statements, and opinions, expressed herein by the hosts and guests are their own, and their appearance on the podcast should not be construed as reflecting the views or implied endorsement of Independent Brokerage Solutions LLC or any of its officers, employees, or agents. The statements made herein should not be considered an investment opinion, advice, or a recommendation regarding securities of any company. This podcast is produced solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy a security.